Cytori receives approval in Japan for Celution cell therapy system
Cytori Therapeutics has received Class III medical device approval in Japan for the Celution cell therapy system.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Dec 18
Cytori Therapeutics has received Class III medical device approval in Japan for the Celution cell therapy system.
30 Nov 18
Aziyo Biologics has secured the US Food and Drug Administration (FDA) clearance for its CanGaroo Envelope device, to…
30 Nov 18
Quidel has received CE Mark for TriageTrue high sensitivity troponin I test, the next-generation diagnostic assay for aid…
29 Nov 18
Amsel Medical has secured 510(k) pre-marketing notification from the US Food and Drug Administration (FDA) for its Amsel…
28 Nov 18
Invivoscribe has submitted LeukoStrat CDx FLT3 mutation assay to both the US FDA and the Japan Pharmaceuticals and…
28 Nov 18
The US Food and Drug Administration (FDA) is planning to overhaul the framework for evaluating the safety and…
27 Nov 18
Ultimaker has been certified by Materialise as a 3D printing solution to create orthopedic, maxillofacial and cardiovascular models…
27 Nov 18
The US Food and Drug Administration (FDA) has approved the ACTPen for Genentech’s Actemra, a single-dose, prefilled autoinjector…
22 Nov 18
Colombia’s INVIMA, the country’s FDA equivalent, completed the review of Hancock Jaffe Laboratories' application for a first-in-human trial…
22 Nov 18
IMBiotechnologies has secured approval from Heath Canada for its Ekobi cmbolization microspheres to treat hypervascularized tumors (HVT) and…